tradingkey.logo

Nanovibronix Inc

NAOV
4.020USD
0.0000.00%
終値 02/06, 16:00ET15分遅れの株価
4.06M時価総額
損失額直近12ヶ月PER

Nanovibronix Inc

4.020
0.0000.00%

詳細情報 Nanovibronix Inc 企業名

NanoVibronix, Inc. is a medical device company focused on developing medical devices utilizing its patented low intensity surface acoustic wave (SAW) technology. The technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including for disruption of biofilms and bacterial colonization, as well as for pain relief. The Company's primary products include PainShield and UroShield, which are portable devices suitable for administration at home or in any care setting. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use.

Nanovibronix Incの企業情報

企業コードNAOV
会社名Nanovibronix Inc
上場日Apr 24, 2015
最高経営責任者「CEO」Besser (Doron)
従業員数15
証券種類Ordinary Share
決算期末Apr 24
本社所在地969 Pruitt Piace
都市TYLER
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号75703
電話番号19142333004
ウェブサイトhttps://nanovibronix.com/
企業コードNAOV
上場日Apr 24, 2015
最高経営責任者「CEO」Besser (Doron)

Nanovibronix Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Stephen Russell (Steve) Brown
Mr. Stephen Russell (Steve) Brown
Chief Financial Officer
Chief Financial Officer
2.00
--
Dr. Harold Jacob, M.D.
Dr. Harold Jacob, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Doron Besser, M.D.
Dr. Doron Besser, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Prof. Zeev Rotstein
Prof. Zeev Rotstein
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Stephen Russell (Steve) Brown
Mr. Stephen Russell (Steve) Brown
Chief Financial Officer
Chief Financial Officer
2.00
--
Dr. Harold Jacob, M.D.
Dr. Harold Jacob, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Doron Besser, M.D.
Dr. Doron Besser, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Prof. Zeev Rotstein
Prof. Zeev Rotstein
Independent Director
Independent Director
--
--

収益内訳

通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
会社から関連データがまだ開示されていません。
地域別USD
会社名
収益
比率
United States
462.00K
93.52%
New Zealand
20.00K
4.05%
Europe
8.00K
1.62%
Other
4.00K
0.81%
事業別
地域別
会社から関連データがまだ開示されていません。

株主

更新時刻: Fri, Jan 2
更新時刻: Fri, Jan 2
株主統計
種類
株主統計
株主統計
比率
Alpha Capital Aktiengesellschaft
0.76%
Geode Capital Management, L.L.C.
0.49%
Armistice Capital LLC
0.37%
Morgan Stanley Smith Barney LLC
0.09%
Tower Research Capital LLC
0.06%
他の
98.23%
株主統計
株主統計
比率
Alpha Capital Aktiengesellschaft
0.76%
Geode Capital Management, L.L.C.
0.49%
Armistice Capital LLC
0.37%
Morgan Stanley Smith Barney LLC
0.09%
Tower Research Capital LLC
0.06%
他の
98.23%
種類
株主統計
比率
Holding Company
0.76%
Investment Advisor/Hedge Fund
0.49%
Hedge Fund
0.42%
Investment Advisor
0.11%
他の
98.21%

機関投資家保有株

更新時刻: Thu, Jan 1
更新時刻: Thu, Jan 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
17
11.24K
1.03%
+4.25K
2025Q3
17
5.95K
0.68%
+2.34K
2025Q2
26
142.96K
5.53%
+80.02K
2025Q1
26
100.49K
7.64%
+70.73K
2024Q4
29
390.46K
7.75%
-206.57K
2024Q3
31
421.26K
15.22%
+83.76K
2024Q2
31
243.60K
8.84%
-214.51K
2024Q1
34
373.91K
18.23%
+170.33K
2023Q4
38
117.62K
5.71%
-262.96K
2023Q3
41
131.29K
7.90%
-1.54K
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
Alpha Capital Aktiengesellschaft
8.25K
0.76%
+4.93K
+148.55%
May 16, 2025
Geode Capital Management, L.L.C.
5.14K
0.47%
--
--
Nov 30, 2025
Armistice Capital LLC
3.99K
0.37%
+3.99K
--
Mar 31, 2025
Morgan Stanley Smith Barney LLC
1.00K
0.09%
+1.00K
--
Sep 30, 2025
Tower Research Capital LLC
627.00
0.06%
+401.00
+177.43%
Sep 30, 2025
The Vanguard Group, Inc.
189.00
0.02%
--
--
Nov 30, 2025
UBS Financial Services, Inc.
35.00
0%
-1.33K
-97.45%
Sep 30, 2025
Fashek (Christopher M)
34.00
0%
--
--
Oct 27, 2025
SBI Securities Co., Ltd.
15.00
0%
+15.00
--
Sep 30, 2025
BofA Global Research (US)
6.00
0%
+5.00
+500.00%
Sep 30, 2025
詳細を見る

関連ETF

銘柄名
比率
データなし

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
配当落ち日
種類
比率
Aug 08, 2025
Merger
10→1
Feb 25, 2025
Merger
11→1
Feb 25, 2025
Merger
11→1
Feb 25, 2025
Merger
11→1
Feb 08, 2023
Merger
20→1
Feb 08, 2023
Merger
20→1
日付
配当落ち日
種類
比率
Aug 08, 2025
Merger
10→1
Feb 25, 2025
Merger
11→1
Feb 25, 2025
Merger
11→1
Feb 25, 2025
Merger
11→1
Feb 08, 2023
Merger
20→1
Feb 08, 2023
Merger
20→1
Feb 08, 2023
Merger
20→1
Feb 08, 2023
Merger
20→1
KeyAI